DEEP-TECH TRENDS
QML at the Edge (via the Cloud): Early Evidence from EEG & Biosignals
What hybrid quantum–classical ML has actually shown—and how to productise it.
Kurzweil’s Timeline for Medical Nanobots Ignores the Hard Parts
Why “nanobots in the bloodstream by the 2030s” underestimates the commercial, clinical and regulatory grind.
Molecules to Materials: Quantum Utility in Drug and Catalyst Discovery
From toy circuits to reproducible hybrid chemistry pipelines.
Biotechnology and DNA Editing: CRISPR’s Commercial Reality
Getting from breakthrough to buyable product.